Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients. A low-field MRI study.

Schmid MP, Mansmann B, Federico M, Dimopoulous JC, Georg P, Fidarova E, Dörr W, Pötter R.

Strahlenther Onkol. 2013 Mar;189(3):238-44. doi: 10.1007/s00066-012-0260-7. Epub 2013 Jan 25.

PMID:
23344563
2.

Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.

Haack S, Pedersen EM, Jespersen SN, Kallehauge JF, Lindegaard JC, Tanderup K.

Acta Oncol. 2010 Oct;49(7):978-83. doi: 10.3109/0284186X.2010.500619.

PMID:
20831485
3.

Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.

Dimopoulos JC, Lang S, Kirisits C, Fidarova EF, Berger D, Georg P, Dörr W, Pötter R.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):56-63. doi: 10.1016/j.ijrobp.2008.10.033. Epub 2009 Mar 14.

PMID:
19289267
4.

Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.

Muschitz S, Petrow P, Briot E, Petit C, De Crevoisier R, Duvillard P, Morice P, Haie-Meder C.

Radiother Oncol. 2004 Nov;73(2):187-94.

PMID:
15542166
5.

Cervical cancer outcome prediction to high-dose rate brachytherapy using quantitative magnetic resonance imaging analysis of tumor response to external beam radiotherapy.

Minkoff D, Gill BS, Kang J, Beriwal S.

Radiother Oncol. 2015 Apr;115(1):78-83. doi: 10.1016/j.radonc.2015.03.007. Epub 2015 Mar 21.

PMID:
25805517
6.

Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy.

Schmid MP, Fidarova E, Pötter R, Petric P, Bauer V, Woehs V, Georg P, Kirchheiner K, Berger D, Kirisits C, Dörr W, Dimopoulos JC.

Acta Oncol. 2013 Oct;52(7):1384-90. doi: 10.3109/0284186X.2013.818251. Epub 2013 Aug 19.

PMID:
23957566
7.

Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.

Strauss HG, Kuhnt T, Laban C, Puschmann D, Pigorsch S, Dunst J, Koelbl H, Haensgen G.

Strahlenther Onkol. 2002 Jul;178(7):378-85.

PMID:
12163992
8.

Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.

Schmid MP, Kirisits C, Nesvacil N, Dimopoulos JC, Berger D, Pötter R.

Radiother Oncol. 2011 Sep;100(3):468-72. doi: 10.1016/j.radonc.2011.08.014. Epub 2011 Sep 14.

9.

Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.

Dyk P, Jiang N, Sun B, DeWees TA, Fowler KJ, Narra V, Garcia-Ramirez JL, Schwarz JK, Grigsby PW.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):794-801. doi: 10.1016/j.ijrobp.2014.07.039. Epub 2014 Sep 20.

PMID:
25245584
10.

Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.

Zhang M, Xu HD, Pan SD, Lin S, Yue JH, Liu JR.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):966-71. doi: 10.1016/j.ijrobp.2011.08.031. Epub 2011 Dec 3.

PMID:
22138462
11.

Prognostic factors in definitive radiotherapy of uterine cervical cancer.

Yalman D, Aras AB, Ozkök S, Duransoy A, Celik OK, Ozsaran Z, Haydaroğlu A.

Eur J Gynaecol Oncol. 2003;24(3-4):309-14.

PMID:
12807246
12.

Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.

Tanderup K, Fokdal LU, Sturdza A, Haie-Meder C, Mazeron R, van Limbergen E, Jürgenliemk-Schulz I, Petric P, Hoskin P, Dörr W, Bentzen SM, Kirisits C, Lindegaard JC, Pötter R.

Radiother Oncol. 2016 Sep;120(3):441-446. doi: 10.1016/j.radonc.2016.05.014. Epub 2016 Jun 24.

PMID:
27350396
13.

MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective.

Lindegaard JC, Fokdal LU, Nielsen SK, Juul-Christensen J, Tanderup K.

Acta Oncol. 2013 Oct;52(7):1510-9. doi: 10.3109/0284186X.2013.818253. Epub 2013 Aug 21.

PMID:
23962242
14.

MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.

Gill BS, Kim H, Houser CJ, Kelley JL, Sukumvanich P, Edwards RP, Comerci JT, Olawaiye AB, Huang M, Courtney-Brooks M, Beriwal S.

Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):540-7. doi: 10.1016/j.ijrobp.2014.10.053. Epub 2015 Jan 30.

PMID:
25680598
15.

3-T MRI-based adaptive brachytherapy for cervix cancer: treatment technique and initial clinical outcomes.

Kharofa J, Morrow N, Kelly T, Rownd J, Paulson E, Rader J, Uyar D, Bradley W, Erickson B.

Brachytherapy. 2014 Jul-Aug;13(4):319-25. doi: 10.1016/j.brachy.2014.03.001. Epub 2014 May 14.

PMID:
24837024
16.

Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.

Koh V, Choo BA, Lee KM, Tan TH, Low JH, Ng SY, Ilancheran A, Shen L, Tang J.

Brachytherapy. 2017 Jan - Feb;16(1):126-132. doi: 10.1016/j.brachy.2016.09.009. Epub 2016 Nov 2.

PMID:
27816539
17.

Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging.

Mayr NA, Yuh WT, Zheng J, Ehrhardt JC, Magnotta VA, Sorosky JI, Pelsang RE, Oberley LW, Hussey DH.

AJR Am J Roentgenol. 1998 Jan;170(1):177-82.

PMID:
9423627
18.

Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.

Tinkle CL, Weinberg V, Chen LM, Littell R, Cunha JAM, Sethi RA, Chan JK, Hsu IC.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1093-1100. doi: 10.1016/j.ijrobp.2015.04.018. Epub 2015 Jul 14.

PMID:
26194683
19.

Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).

Nakamura K, Kitahara Y, Satoh T, Takei Y, Takano M, Nagao S, Sekiguchi I, Suzuki M.

World J Surg Oncol. 2016 Jun 29;14(1):173. doi: 10.1186/s12957-016-0931-4.

20.

Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy.

Rijkmans EC, Nout RA, Rutten IH, Ketelaars M, Neelis KJ, Laman MS, Coen VL, Gaarenstroom KN, Kroep JR, Creutzberg CL.

Gynecol Oncol. 2014 Nov;135(2):231-8. doi: 10.1016/j.ygyno.2014.08.027. Epub 2014 Aug 27.

PMID:
25172763

Supplemental Content

Support Center